Issue of Equity
Castleton Technology PLC
("Castleton" "the Company" or the "Group'')
Issue of Equity
Castleton Technology PLC (AIM: CTP), a leading supplier of complementary software and managed services to the public and not-for-profit sectors, announces that it has allotted a total of 110,820 new ordinary shares of 2 pence each in the capital of the Company ("Ordinary Shares") following the exercise of 110,820 options over Ordinary Shares by three employees.
Application has been made to the London Stock Exchange for the 110,820 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 6 August 2019.
After Admission of the new Ordinary Shares, the total number of Ordinary Shares in issue will be 81,709,810 and the total number of voting rights will therefore be 81,709,810. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.
Enquiries:
Castleton Technology plc Dean Dickinson, Chief Executive Officer Haywood Chapman, Chief Financial Officer
| Tel. +44 (0)845 241 0220
|
finnCap Ltd Jonny Franklin-Adams / Simon Hicks
| Tel. +44 (0)20 7220 0500 |
Alma PR Rebecca Sanders-Hewett / Helena Bogle / Josh Royston | Tel. +44(0) 7780 901979 |
About Castleton Technology plc
Castleton Technology plc is a leading supplier of complementary software and managed services to the public and not-for-profit sectors. The Group is a 'one stop shop', providing integrated housing systems via the Cloud, working in partnership with its customers and resellers to help drive efficiencies whilst improving controls and customer service. www.castletonplc.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.